NIFTY 50 Close 28 Oct

ICICI Prudential Nifty Pharma Index Fund

Sectoral · Direct Growth Very High Risk

₹20.5433
NAV on 28-Oct-2026
Showing the Direct plan. The Regular plan you picked has the same portfolio but a higher expense ratio, so its NAV and returns are lower.
Fund size (AUM)
₹163 Cr
Expense ratio
0.51%
Since inception (CAGR)
+20.42%
Minimum SIP · lump sum
₹1,000 · ₹1,000

Returns

absolute up to 1Y, annualised beyond
1M3M6M1Y3Y5Y10Y
This fund-0.87%+2.02%+14.73%+19.40%+21.68%——
Category average—-4.89%+7.29%+6.47%+20.21%+14.60%—

About

Fund houseICICI Prudential Mutual Fund
Fund managersNishit Patel
BenchmarkNIFTY Pharma Total Return Index
Launched14-Dec-2022
ISININF109KC11M9
Exit load—

Risk

Standard deviation16.17
Sharpe ratio0.85
Sortino ratio1.59
Alpha-0.42
Beta0.94

Top holdings

22 in total
HoldingSectorValue% of fund
Sun Pharmaceutical Industries LtdHealthcare₹32 Cr19.50%
Divi's Laboratories LtdHealthcare₹20 Cr11.97%
Laurus Labs LtdHealthcare₹13 Cr7.82%
Cipla LtdHealthcare₹13 Cr7.68%
Dr. Reddy's Laboratories LtdHealthcare₹12 Cr7.62%
Torrent Pharmaceuticals LtdHealthcare₹12 Cr7.16%
Lupin LtdHealthcare₹8 Cr5.00%
Aurobindo Pharma LtdHealthcare₹8 Cr4.68%
Glenmark Pharmaceuticals LtdHealthcare₹6 Cr3.56%
Alkem Laboratories LtdHealthcare₹5 Cr3.16%
Zydus Lifesciences LtdHealthcare₹5 Cr2.92%
Mankind Pharma Ltd.Healthcare₹5 Cr2.88%
Ipca Laboratories LtdHealthcare₹4 Cr2.71%
Biocon LtdHealthcare₹4 Cr2.62%
Gland Pharma LtdHealthcare₹4 Cr2.34%
Sai Life Sciences Ltd.Healthcare₹3 Cr2.14%
Wockhardt LtdHealthcare₹3 Cr1.77%
Ajanta Pharma LtdHealthcare₹3 Cr1.67%
RepoUnspecified₹2 Cr1.50%
Abbott India LtdHealthcare₹2 Cr1.43%

Fetched 29 Oct, 17:38 IST. Past returns don't predict future returns. Source: Indian Stock API.